JPRN-UMIN000007514已完成2 期
Phase ll Study of Postoperative Adalimumab Maintenance Therapy for Crohn's Disease Recurrence - PAD study
agoya University Gradeate School of Medicine Department of Gastroenterology0 个研究点目标入组 25 人开始时间: 2012年3月15日最近更新:
适应症
试验速览
- 阶段
- 2 期
- 状态
- 已完成
- 发起方
- 入组人数
- 25
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 20years-old 至 ot applicable（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •(1)Uncontrolled infection (2)Confirmed opportunistic infection diseases within 6 months (3)Tuberculosis or a history of it (4)most positive tuberculin skin test (5)Active hepatitis B, C or a history of hepatitis C (6)Confirmed HIV infection (7)Demyelinating disease or a history of it (8)History of lymphoproliferative disorder, or suspicion of lymphoproliferative disorder or splenomegaly (9)Lupus syndrome, and positive anti-dsDNA antibody (10)malignant tumor (11)Clinically abnormal electrocardiogram or cardiovascular disease. (12)Severe pulmonary disease (13)Interstitial pneumonia or pulmonary fibrosis or a history of those (14)Severe hepatic disease (15)Severe renal failure (16)Severe drug allergies (17)Bowel obstraction or bowel paresis (18)Severe or uncontrollable complications (diabetes mellitus, hypertention, diarrhea, electrolyte abnormality, etc.) (19)Psychiatric disorder, central nervous system damage, cerebrovascular diseases (20)Pregnant women, possibly pregnant women, wishing to become pregnant, and nursing mothers. (21)Not appropriate for the study at the physician's assessment.
研究者
相似试验
招募中
4 期
Prospective follow-up study of adalimumab treatment in ankylosing spondylitis: efficacy with focus on uveitisAnkylosing spondylitisBechterew's disease10023213NL-OMON30515Vrije Universiteit Medisch Centrum100
招募中
不适用
Efficacy of maintenance therapy with adalimumab in ulcerative colitis achieving remission with tacrolimusulcerative colitisJPRN-UMIN000015912Osaka Medical College50
尚未招募
2 期
The effect of Adalimumab in the treatment of patients with chronic schizophreniaSchizophrenia.SchizophreniaIRCT20090117001556N126Tehran University of Medical Sciences50
进行中（未招募）
1 期
Study to Evaluate the Safety and Efficacy of Adalimumab in MPS I, II, and VIMucopolysaccharidosis IMucopolysaccharidosis IIMucopolysaccharidosis VINCT03153319Lundquist Institute for Biomedical Innovation at Harbor-UCLA Medical Center14
已完成
4 期
Safety and Efficacy of Adalimumab (Humira) for Hidradenitis Suppurativa (HS) Peri-SurgicallyHidradenitis Suppurativa (HS)NCT02808975AbbVie206